NCT01672151View on ClinicalTrials.gov

Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Immune Thrombocytopenic Purpura
Interventions
DRUG

rapamycin

4mg oral administration on the first day, 2 mg/d oral administration for 3 months

Trial Locations (1)

215006

Jiangsu Institute of Hematology, Suzhou

All Listed Sponsors
lead

First Affiliated Hospital of Suzhou Medical College

OTHER

NCT01672151 - Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia | Biotech Hunter | Biotech Hunter